Current status of the prediction for radio-iodine refractory thyroid cancer: a narrative review

Y Wang, X Lu, H Liu - Frontiers in Endocrinology, 2024 - frontiersin.org
It is well established that patients with the most differentiated thyroid cancers have a good
prognosis, whereas when the disease develops into radio-iodine refractory thyroid cancer …

The relationship between oxidative status and radioiodine treatment qualification among papillary thyroid cancer patients

A Buczyńska, I Sidorkiewicz, M Kościuszko, A Adamska… - Cancers, 2023 - mdpi.com
Simple Summary Studies analyzing the protein profile of thyroid tissue in patients with
papillary thyroid cancer (PTC) have revealed disturbed metabolic pathways, including those …

Research trends and hotspots of radioiodine-refractory thyroid cancer treatment in the twenty-first century: a bibliometric analysis

Y Xue, Y Zhang, X Ding, X Wu, B Li, Y Zhang… - Annals of Nuclear …, 2024 - Springer
The treatment of radioiodine-refractory differentiated thyroid cancer (RAIR-DTC) has made
significant advancements in the twenty-first century. This study aimed to assess the current …

TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression

C Zeng, Y Zhang, C Lin, W Liang, J Chen… - Journal of …, 2024 - Springer
Purpose Thyroid cancer has an overwhelming incidence in the population. Thus, there is an
urgent need to understand the underlying mechanism of its occurrence and development …